Oral medicine| Volume 115, ISSUE 3, P354-358, March 2013

Microbiology and epidemiology of oral yeast colonization in hemopoietic progenitor cell transplant recipients

Published:January 10, 2013DOI:


      We monitored the epidemiology and microbiology of oral yeast colonization in patients undergoing hemopoietic progenitor cell transplantation (HPCT) to examine associations between yeast colonization and oral mucositis.

      Study Design

      One hundred twenty-one consecutive HPCT patients were sampled for oral yeasts prior to fluconazole (FLC) prophylaxis, at transplantation, and weekly until discharge. Clinical oral mucositis screenings were performed triweekly.


      Yeast colonization was evident at 216 of 510 total visits. Candida albicans and Candida glabrata were the predominant organisms. Eight patients showed elevated minimal inhibitory concentrations to FLC. One patient developed fungal septicemia. Patients with oral mucositis assessment scale scores <20 had higher colonization rates than those with higher scores.


      FLC is effective in controlling a variety of oral yeasts in HPCT recipients. FLC-resistant yeasts do emerge and can be the source of fungal sepsis. A positive association was not shown between yeast colonization and the presence or severity of oral mucositis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Copelan E.A.
        Hematopoietic stem-cell transplantation.
        N Engl J Med. 2006; 354: 1813-1826
        • Epstein J.B.
        • Raber-Durlacher J.E.
        • Wilkins A.
        • Chavarria M.G.
        • Myint H.
        Advances in hematologic stem cell transplant: an update for oral health care providers.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 107: 301-312
        • Kontoyiannis D.P.
        • Marr K.A.
        • Park B.J.
        • Alexander B.D.
        • Anaissie E.J.
        • Walsh T.J.
        • et al.
        Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
        Clin Infect Dis. 2010; 50: 1091-1100
        • Marr K.A.
        • Bow E.
        • Chiller T.
        • Maschmeyer G.
        • Ribaud P.
        • Segal B.
        • et al.
        Fungal infection prevention after hematopoietic cell transplantation.
        Bone Marrow Transplant. 2009; 44: 483-487
        • Wirk B.
        • Wingard J.R.
        Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients.
        Mycopathologia. 2009; 168: 299-311
        • Goodman J.L.
        • Winston D.J.
        • Greenfield R.A.
        • Chandrasekar P.H.
        • Fox B.
        • Kaizer H.
        • et al.
        A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
        N Engl J Med. 1992; 326: 845-851
        • Redding S.W.
        • Marr K.A.
        • Kirkpatrick W.R.
        • Coco B.J.
        • Patterson T.F.
        Candida glabrata sepsis secondary to oral colonization in bone marrow transplantation.
        Med Mycol. 2004; 42: 479-481
        • Westbrook S.D.
        • Kirkpatrick W.R.
        • Freytes C.O.
        • Toro J.J.
        • Bernardo S.
        • Patterson T.F.
        • et al.
        Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient.
        Med Mycol. 2007; 45: 187-190
        • Blijlevens N.
        • Schwenkglenks M.
        • Bacon P.
        • D'Addio A.
        • Einsele H.
        • Maertens J.
        • et al.
        Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group.
        J Clin Oncol. 2008; 26: 1519-1525
        • Laheij A.M.
        • de Soet J.J.
        • von dem Borne P.A.
        • Kuijper E.J.
        • Kraneveld E.A.
        • van Loveren C.
        • Raber-Durlacher J.E.
        Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients.
        Support Care Cancer. 2012; 20: 3231-3240
        • Keefe D.M.
        • Schubert M.M.
        • Elting L.S.
        • Sonis S.T.
        • Epstein J.B.
        • Raber-Durlacher J.E.
        • et al.
        Updated clinical practice guidelines for the prevention and treatment of mucositis.
        Cancer. 2007; 109: 820-831
        • Sonis S.T.
        • Elting L.S.
        • Keefe D.
        • Peterson D.E.
        • Schubert M.
        • Hauer-Jensen M.
        • et al.
        Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.
        Cancer. 2004; 100: 1995-2025
        • Jones J.A.
        • Qazilbash M.H.
        • Shih Y.C.
        • Cantor S.B.
        • Cooksley C.D.
        • Elting L.S.
        In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample.
        Cancer. 2008; 112: 1096-1105
        • Patterson T.F.
        • Revankar S.G.
        • Kirkpatrick W.R.
        • Dib O.
        • Fothergill A.W.
        • Redding S.W.
        • et al.
        Simple method for detecting fluconazole-resistant yeasts with chromogenic agar.
        J Clin Microbiol. 1996; 34: 1794-1797
        • World Health Organization
        WHO handbook for reporting results of cancer treatment.
        World Health Organization, Geneva1979
        • Sonis S.T.
        • Eilers J.P.
        • Epstein J.B.
        • LeVeque F.G.
        • Liggett Jr, W.H.
        • Mulagha M.T.
        • et al.
        Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group.
        Cancer. 1999; 85: 2103-2113
        • CLSI
        Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard.
        3d ed. Clinical and Laboratory Standards Institute, Wayne, PA2008 (p. M27-A3)
        • Rex J.H.
        • Pfaller M.A.
        • Galgiani J.N.
        • Bartlett M.S.
        • Espinel-Ingroff A.
        • Ghannoum M.A.
        • et al.
        Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro–in vivo correlation data for fluconazole, itraconazole, and Candida infections.
        Clin Infect Dis. 1997; 24: 235-247
        • Westbrook S.D.
        • Wiederhold N.P.
        • Vallor A.C.
        • Kotara S.
        • Bernardo S.
        • Lee S.A.
        • et al.
        Loss of in vitro resistance in Candida glabrata following discontinuation of fluconazole prophylaxis in a hematopoietic stem cell transplantation patient.
        Med Mycol. 2010; 48: 557-560
        • Epstein J.B.
        • Hancock P.J.
        • Nantel S.
        Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003; 96: 154-163